EXACT Therapeutics AS (DE:56F) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
EXACT Therapeutics has secured a $7 million investment from GE HealthCare to advance its Acoustic Cluster Therapy (ACT) for pancreatic cancer. This strategic collaboration aims to support EXACT’s Phase 2 ENACT study and includes a four-year agreement for the development and supply of clinical equipment. The partnership highlights a significant step in therapeutic ultrasound, potentially transforming cancer treatment.
For further insights into DE:56F stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘Time to Jump Ship,’ Says Investor About MicroStrategy Stock
- Nvidia and Microsoft: Why This Top Investment Firm Decided to Dump Shares
- Wells Fargo (NYSE:WFC) Departs Philadelphia Sports Arena
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
